Ziegler is pleased to announce it served as the exclusive financial advisor to EmVenio Research in its recent sale to PCM Trials. Founded in 2020 in Durham, North Carolina, EmVenio Research began as a division of Matrix Medical Network during the COVID-19 pandemic and spun out as an independent company in 2022. The company provides mobile research units (MRUs) and other decentralized clinical trial services to accelerate clinical trials.